Aligning science, partners and strategy.
Syzent Partners advances life science products and technologies to meet value-added milestones: partnerships, grants and financings, all on the road to commercialization.
Our work is based on rigorous assessment of unmet medical needs and product advantages.
- Unmet medical need Every program starts with a clear-eyed view of the clinical problem it solves.
- Proof-of-concept Robust data that shows partners and investors the commercial upside.
- INTELLECTUAL PROPERTY Rigorous review of freedom to operate and potential new applications
- Market & partners Assessment of competition and market to ensure strong potential
Built on transparency, integrity and commitment.
Our business philosophy is anchored on three principles.
-
I
Transparency
We always disclose potential conflicts of interest, and our conclusions are evidence-based and shared openly with management, investors and partners.
-
II
Integrity
Clear strategic thinking and honest assessment of the science, the market and the deal — even when the answer is not the one people hoped for.
-
III
Commitment to partner goals
We act as a catalyst for management teams, investors and partners, and we stay alongside our clients to implement initiatives and keep moving forward.
Michael Atkin
Michael Atkin founded Syzent Partners and has many years of experience advancing early-stage life sciences products and technologies towards commercialization.
- Decades of leadership across both global conglomerates and agile biotechnology innovators
- A corporate track record in multinational Fortune 100 and 200 pharmaceuticals, consumer brands, chemicals and industrial manufacturing
- Deep experience in preclinical and clinical-stage biotechnology firms working with first-in-class, follow-on and next-generation drugs and biologics
- Closed five life science out-licenses, three in-licenses, three company sales, two acquisitions, renegotiated two supply agreements and closed one merger
- Divested six consumer brands to four purchasers, including settlement of two lawsuits
- Closed an aerospace acquisition, a high-technology merger and a chemical divestiture
When a project needs additional skills, Syzent strengthens the team with experienced professionals who are fully briefed on the client’s needs and project background.
Read full biographyBuilt on transparency, integrity and commitment.
Our business philosophy is anchored on three principles.
Commercial leadership & product development
For early-stage life sciences research.
- Address unmet medical needs
- Build marketable differentiators
- Show clear benefits over existing products and pipeline approaches
Fundraising & grant writing
Clear, strong writing that highlights the advantages of the technology.
- Non-confidential and confidential technology summaries
- Presentation materials
- Discussions with potential investors
Licensing & business development
From first contact to signed agreement.
- Non-confidential and confidential materials
- Meetings with potential partners
- Structuring and negotiating transactions
- Finalizing legal documents
Spin-out versus license
Timing the decision on market dynamics and investor and partner demand.
- Spin-out or license recommendation
- Structuring spin-out companies for commercial success
Market research & competitive intelligence
Evidence for every strategic decision.
- Market assessment studies
- Key opinion leader (KOL) development
Strategic planning
Business plans that connect science, market and financing.
- Strategic planning
- Business plan development
Built on transparency, integrity and commitment.
Our business philosophy is anchored on three principles.
- Laboratories
- With thanks to Professor Gabriella Gobbi, MD, PhD, and Professor Sylvain Martel, PhD, for permission to photograph in their laboratories.
- Photography
- Laboratory photographs by Michael Atkin. Portrait of Michael Atkin by Tobias Atkin. Shot on a Hasselblad 500 C/M with a Carl Zeiss lens on Ilford film.
- Logo
- The Syzent logo incorporates a photograph of the 2006 solar eclipse, courtesy of NASA.
- Use of photographs
- Photographs may be reproduced for non-commercial purposes with attribution to Syzent.com.
Let's align strategy with opportunity.
For clinical and pre-IND life sciences companies seeking the right strategic partnership.
Life sciences partnerships, financings, grants and development milestones don’t happen by accident. We need to line up all the elements to close the deal.